iPSC model helps to better understand genetic lung/liver disease

2 abril 2015

Using patient-derived stem cells known as induced pluripotent stem cells (iPSC) to study the genetic lung/liver disease called alpha-1 antitrypsin deficiency, researchers have for the first time created a disease signature that may help explain how abnormal protein leads to liver disease.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/nGVziPY26F0/150402132749.htm